Medico Remedies Limited has informed the Exchange about Action(s) taken or orders passed
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medico Remedies Limited received SoP (Standard Operating Procedure) notices from both NSE and BSE on 20th February 2026 for alleged non-compliance with Regulation 6(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Each exchange levied a penalty of Rs. 63,720/- (inclusive of GST). The company filed waiver applications on 24th February 2026, which were subsequently rejected by both BSE on 5th March 2026 and NSE on 10th April 2026. The company has already paid the fines and became compliant with the regulation effective 18th February 2026. The company cited inadvertent delay in disclosure and has committed to ensuring timely disclosures in the future.
This is a relatively minor compliance issue with limited financial impact of approximately Rs. 1.27 lakh total penalty. The company has already settled the fines and restored compliance, reducing the risk of further regulatory action. However, it highlights governance gaps in timely disclosure practices.